Lab Space, Big Bets, and the Build-Out of The Region’s Innovation Economy

What We’ll Cover

• What’s actually being built, converted, and delivered in the Dallas-Fort Worth region. Where spec development is happening, where it’s stalling, and what the supply picture looks like heading into 2026 and beyond.
• How developers and general contractors are evaluating existing shells, flex, and office product for life sciences conversion, when it makes more sense to build from scratch, and what it actually takes operationally — not just financially — to make that conversion pencil.
• Understanding the gap between what the DFW market can deliver today and what biotech, medtech, and clinical tenants are asking for when they go to sign a lease, from flexible lab space that has to evolve into cleanroom, GMP, and biomanufacturing-ready space, to the refrigeration and utility infrastructure that increasingly defines a deal (DFW now trails only Miami in cold storage capacity).
• Breaking down why capital sources are increasingly turning their attention to Dallas-Fort Worth: the momentum building out of Pegasus Park and BioLabs, venture dollars connecting local companies to investors on both coasts, the validation coming from Texas’s growing NASDAQ and financial-sector presence, and state-backed programs like CPRIT.
• A look at how life sciences deals are getting structured and financed, what returns investors are underwriting, and how the risk profile compares to other asset classes and to other life sciences hubs.
• The workforce question behind the real estate: how Dallas College, Texas A&M’s new biomedical campus in Fort Worth, and ties to UTSW’s clinical infrastructure are shaping whether DFW can build the technician and technical talent pipeline life sciences tenants actually need — plus how AI and automation are already changing what “lab of the future” space has to look like.